Cargando…
FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ
The proliferation, migration and apoptotic resistance of pulmonary artery smooth muscle cells (PASMCs) are central to the progression of pulmonary arterial hypertension (PAH). Our previous study identified that fibroblast growth factor 21 (FGF21) regulates signalling pathway molecules, such as perox...
Autores principales: | Wang, Meibin, Su, Lihuang, Sun, Junwei, Cai, Luqiong, Li, Xiuchun, Zhu, Xiayan, Song, Lanlan, Li, Jingyin, Tong, Shuolan, He, Qinlian, Cai, Mengsi, Yang, Lehe, Chen, Yanfan, Wang, Liangxing, Huang, Xiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831951/ https://www.ncbi.nlm.nih.gov/pubmed/34989130 http://dx.doi.org/10.1111/jcmm.17154 |
Ejemplares similares
-
FGF21 attenuates hypoxia-induced dysfunction and inflammation in HPAECs via the microRNA-27b-mediated PPARγ pathway
por: Yao, Dan, et al.
Publicado: (2021) -
FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19
por: Li, Xiuchun, et al.
Publicado: (2022) -
Downregulation of CPA4 inhibits non small–cell lung cancer growth by suppressing the AKT/c‐MYC pathway
por: Fu, Yangyang, et al.
Publicado: (2019) -
Circ-Ntrk2 acts as a miR-296-5p sponge to activate the TGF-β1/p38 MAPK pathway and promote pulmonary hypertension and vascular remodelling
por: Su, Lihuang, et al.
Publicado: (2023) -
The emerging role of the piRNA/PIWI complex in respiratory tract diseases
por: Yao, Yizhu, et al.
Publicado: (2023)